| 000 | 01907 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518030437.0 | ||
| 264 | 0 | _c20200205 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1878-3562 | ||
| 024 | 7 |
_a10.1016/j.dld.2019.02.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFiorino, Gionata | |
| 245 | 0 | 0 |
_aUse of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). _h[electronic resource] |
| 260 |
_bDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _c05 2019 |
||
| 300 |
_a632-639 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aCaprioli, Flavio | |
| 700 | 1 | _aDaperno, Marco | |
| 700 | 1 | _aMocciaro, Filippo | |
| 700 | 1 | _aPrincipi, Mariabeatrice | |
| 700 | 1 | _aViscido, Angelo | |
| 700 | 1 | _aFantini, Massimo Claudio | |
| 700 | 1 | _aOrlando, Ambrogio | |
| 700 | 1 | _aPapi, Claudio | |
| 700 | 1 | _aAnnese, Vito | |
| 700 | 1 | _aDanese, Silvio | |
| 700 | 1 | _aVecchi, Maurizio | |
| 700 | 1 | _aRizzello, Fernando | |
| 700 | 1 | _aArmuzzi, Alessandro | |
| 773 | 0 |
_tDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver _gvol. 51 _gno. 5 _gp. 632-639 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dld.2019.02.004 _zAvailable from publisher's website |
| 999 |
_c29478025 _d29478025 |
||